Biotech suppliers often sell to buyers with complex approval paths, grant-funded budgets, and longer invoice cycles. Research institutions, hospitals, pharmaceutical companies, and contract research organizations may need flexible payment terms before they can complete purchases for lab equipment, reagents, diagnostics, research tools, and other high-value supplies. That creates a familiar challenge for suppliers: buyers want more time to pay, but the supplier still needs predictable cash flow to replenish inventory, support operations, and keep customer relationships moving.
Healthcare payment pressure can also affect the broader supply chain. Hospitals absorbed $130 billion in Medicare and Medicaid underpayments in 2023, while research organizations often operate within grant and procurement rules shaped by agencies such as the NIH grants policy. For biotech suppliers, the right net terms solution should support buyer flexibility without turning the supplier into the lender, collections team, and credit department. Resolve Pay’s B2B Net Terms platform helps suppliers offer payment terms, automate accounts receivable, manage buyer credit decisions, and receive advance payment on approved invoices while reducing credit risk.
Resolve Pay offers biotech suppliers a practical way to extend net terms while reducing the risk and operational strain that usually comes with trade credit. The platform combines embedded credit expertise, advance pay, payment processing, collections workflows, and AR automation so suppliers can support institutional buyers without managing every step manually.
Biotech suppliers that need to offer payment terms to research institutions, hospitals, pharmaceutical companies, universities, distributors, and other B2B buyers while protecting cash flow and reducing credit exposure.
Resolve Pay is especially useful for biotech suppliers that serve buyers with longer procurement cycles and formal approval processes. Research institutions and healthcare organizations may need time to process invoices, align purchases with budgets, or follow internal procurement controls. The NIH procurement standards show how structured procurement requirements can shape purchasing behavior for grant-funded organizations.
With Resolve Pay, suppliers can offer net terms while receiving advance payment on approved invoices. That helps reduce the cash flow gap between order fulfillment and final buyer payment. The platform also helps manage the credit-to-cash lifecycle, including buyer credit assessment, invoicing, payment reminders, collections workflows, and reconciliation.
Resolve Pay enables B2B suppliers to offer payment terms while reducing the manual workload that often falls on finance and AR teams. Its business credit checks support fast buyer assessments, while automated workflows help teams reduce manual follow-up and keep invoice activity organized.
For biotech suppliers, this matters because customer relationships often depend on trust, speed, and flexible purchasing options. Resolve Pay helps suppliers support those expectations while maintaining a more predictable receivables process.
Balance provides B2B payment and trade credit tools designed for digital commerce and marketplace environments. Its platform focuses on checkout, invoicing, and buyer payment experiences for B2B transactions.
Biotech suppliers that sell through digital channels or marketplaces and need a B2B checkout experience with trade credit options.
Balance may be relevant for biotech suppliers that rely heavily on online sales channels or marketplace-style purchasing. Its emphasis on digital checkout can support buyers that prefer a self-service purchasing flow.
For suppliers that also need deeper AR automation, advance pay, credit management, collections workflows, and embedded net terms across online and offline sales, Resolve Pay offers a broader credit-to-cash platform built around B2B supplier cash flow.
Credit Key provides B2B trade credit and net terms options, with a focus on helping merchants offer financing at checkout. It is often used by businesses that want to give buyers a structured way to pay over time.
Biotech suppliers that sell online and want a checkout-focused financing option for eligible B2B buyers.
Credit Key can be relevant for biotech suppliers that want to add a buyer financing option to ecommerce transactions. This may help reduce friction for buyers that need payment flexibility during checkout.
Biotech suppliers with broader AR needs may require more than checkout financing. Resolve Pay supports net terms management, advance pay, buyer credit decisions, AR automation, and collections workflows, which can be useful when sales happen through ecommerce, direct sales, field reps, or invoice-based processes.
HighRadius provides enterprise accounts receivable and order-to-cash automation for large organizations. Its platform includes tools for credit, collections, cash application, deductions, and treasury workflows.
Large biotech companies with complex enterprise receivables operations and high-volume finance workflows.
HighRadius may fit large biotech companies that already have enterprise finance infrastructure and need order-to-cash automation across complex entities, geographies, and transaction volumes.
For biotech suppliers seeking embedded net terms, advance pay on approved invoices, buyer-facing payment workflows, and a platform designed to help suppliers get paid faster while offering customer terms, Resolve Pay provides a focused B2B payments and net terms option.
Tipalti provides global payables automation and supplier payment tools. Its platform is commonly associated with accounts payable, supplier onboarding, tax form collection, and international payment operations.
Biotech companies managing vendor payments, contract research organization payments, supplier onboarding, and global AP workflows.
Tipalti may be relevant for biotech companies that need to manage outgoing vendor payments across international supplier networks. This can include payments to contract research organizations, service providers, or research vendors.
For biotech suppliers focused on customer receivables, net terms, advance pay, and credit-to-cash workflows, Resolve Pay is more directly aligned with the supplier-side challenge of offering payment terms while protecting cash flow.
TreviPay provides B2B trade credit and invoicing solutions for companies that need to offer purchasing programs to business buyers. Its tools support trade credit workflows, invoicing, and payment management.
Biotech suppliers that need a trade credit program with established B2B invoicing and payment workflows.
TreviPay may support biotech suppliers with established trade credit needs and international B2B buyer relationships. Its trade credit model can help suppliers offer structured invoice payment options to business buyers.
Resolve Pay remains a strong fit for suppliers that want net terms, advance pay, embedded credit expertise, AR automation, and integrations in one platform. Its integrations with financial systems help suppliers connect payment workflows with existing accounting, ERP, and ecommerce tools.
Billtrust provides accounts receivable automation, invoicing, payments, collections, and cash application tools for businesses with complex receivables workflows.
Biotech suppliers and healthcare-adjacent businesses that need AR automation, invoice delivery, payment acceptance, and cash application support.
Billtrust may be relevant for biotech suppliers with complex invoicing processes, multiple buyer entities, or high transaction volumes. Its AR automation tools can support invoice management and payment processing.
For suppliers that also need embedded net terms and advance pay on approved invoices, Resolve Pay adds a cash flow component to the AR workflow. That can be important when biotech buyers require time to pay, but suppliers need working capital sooner.
BILL provides AP and AR automation tools for small and midsize businesses. Its platform supports invoice management, payments, approvals, and accounting integrations.
Early-stage and small biotech companies that need basic AP and AR automation with accounting system connectivity.
BILL can help smaller biotech companies organize routine payment workflows and reduce manual finance tasks. It may be useful for teams that need basic automation without a complex enterprise implementation.
For biotech suppliers focused on net terms and customer credit, Resolve Pay provides a more specialized B2B payment terms platform. Its seller payment tools are designed to help suppliers offer terms, reduce risk, and improve cash flow from approved invoices.
Selecting a net terms solution for biotech suppliers requires a careful look at how your buyers purchase, how long they take to pay, and how much manual AR work your team can handle. Biotech suppliers often work with buyers that have structured procurement processes, budget timing constraints, and internal payment approval steps. Some buyers may also operate under research funding rules, healthcare reimbursement pressure, or institutional purchasing policies.
Resolve Pay is built for suppliers that want to offer flexible terms without carrying the full burden of credit risk, collections, and delayed cash flow. Its non-recourse advance pay model can help suppliers get paid faster on approved invoices, while customers keep the payment terms they need. Its AI-powered credit decisions and expert review help suppliers assess buyer creditworthiness without slowing down order fulfillment.
The platform also supports the operational side of B2B payments. Resolve Pay can automate invoicing, reminders, payment workflows, collections management, and reconciliation. With QuickBooks integration and broader ERP, accounting, and ecommerce connectivity, suppliers can connect net terms workflows to the systems they already use.
As biotech suppliers grow, payment operations often become more complex. A manual process that works for a small customer base can become difficult to manage when invoices increase, buyers request longer terms, and finance teams need cleaner reconciliation. Resolve Pay helps turn net terms into a scalable sales and finance tool by combining credit, payments, AR automation, and advance pay in one platform.
Net terms can help biotech suppliers win and retain buyers that need more time to pay. With Resolve Pay, suppliers can offer terms to approved customers while receiving advance payment on approved invoices. This helps reduce the cash flow strain that can come from waiting for research institutions, hospitals, pharmaceutical companies, or distributors to complete their payment cycles.
With recourse financing, the supplier may still be responsible if the buyer does not pay. With non-recourse financing, the financing provider assumes the covered credit risk under the approved terms. Resolve Pay’s factoring alternative is designed to help suppliers receive advance payment on approved invoices while reducing the risk and administrative work associated with offering net terms.
Resolve Pay supports risk reduction through AI-powered credit decisions, expert credit review, non-recourse advance pay on approved invoices, payment workflows, reminders, and collections management. Instead of asking biotech suppliers to manage every credit and collections task manually, Resolve Pay helps structure the credit-to-cash lifecycle in one platform.
Yes. Resolve Pay supports integrations with accounting, ERP, and ecommerce systems, including QuickBooks Online, NetSuite, Xero, Sage Intacct, Shopify, BigCommerce, Magento, WooCommerce, and other platforms. These integrations help automate invoice syncing, payment updates, and reconciliation.
Resolve Pay can advance payment on approved invoices within 24 hours, depending on buyer approval, invoice approval, and underwriting requirements. This helps biotech suppliers offer customer-friendly payment terms while keeping cash flow more predictable.
This post is to be used for informational purposes only and does not constitute formal legal, business, or tax advice. Each person should consult his or her own attorney, business advisor, or tax advisor with respect to matters referenced in this post. Resolve assumes no liability for actions taken in reliance upon the information contained herein.